4.7 Review

Hydrogen/deuterium exchange mass spectrometry for probing higher order structure of protein therapeutics: methodology and applications

期刊

DRUG DISCOVERY TODAY
卷 19, 期 1, 页码 95-102

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2013.07.019

关键词

-

资金

  1. Bristol-Myers Squibb
  2. National Institutes of Health [R01-GM086507, R01-101135]
  3. research collaboration with the Waters Corporation
  4. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101135, R01GM086507] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The higher order structure of protein therapeutics can be interrogated with hydrogen/deuterium exchange mass spectrometry (HDX-MS). HDX-MS is now a widely used tool in the structural characterization of protein therapeutics. In this review, HDX-MS based workflows designed for protein therapeutic discovery and development processes are presented, focusing on the specific applications of epitope mapping for protein/drug interactions and biopharmaceutical comparability studies. Future trends in the application of HDX-MS in protein therapeutics characterization are also described.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据